Biotech company Amgen announced Friday a $900-million expansion of its New Albany manufacturing facility that will add 350 jobs.
The facility now employs 400 people. Amgen said the expansion will bring its total investment in central Ohio to $1.4 billion.
Workers at the plant assemble and package medicines. The facility opened in February 2024.
“Ohio has built a strong foundation for economic development, which has led companies like Amgen to see Ohio as a premier destination for growth,” Gov. Mike DeWine said in a statement Amgen provided. “We are happy to see Amgen deepen its commitment to our state and look forward to the innovation and economic impact it will drive.”
Robert A. Bradway, Amgen's chairman and chief executive officer, said in a statement that the new investment reinforces the company's ongoing commitment to expanding U.S. manufacturing.
“Ohio offers a supportive business climate, skilled workforce, and strategic location, making it an ideal choice for this next phase of our investment,” Bradway said.